Published in Int J Nanomedicine on December 05, 2013
Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical. Int J Nanomedicine (2016) 0.82
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging (Albany NY) (2017) 0.79
Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway. Int J Nanomedicine (2014) 0.78
Berberine nanosuspension enhances hypoglycemic efficacy on streptozotocin induced diabetic C57BL/6 mice. Evid Based Complement Alternat Med (2015) 0.76
Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice. Int J Nanomedicine (2015) 0.76
Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status. Int J Nanomedicine (2017) 0.75
The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A (2008) 7.06
The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng (2012) 4.31
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes (2006) 4.14
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med (2004) 3.92
Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab (2007) 2.09
Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol (2009) 1.86
Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small (2009) 1.68
Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma. Biol Pharm Bull (2005) 1.64
Applications of novel drug delivery system for herbal formulations. Fitoterapia (2010) 1.57
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One (2012) 1.46
Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS One (2011) 1.35
Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos (2010) 1.23
Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry. J Pharm Biomed Anal (2007) 1.17
Acute toxicity of berberine and its correlation with the blood concentration in mice. Food Chem Toxicol (2010) 1.14
Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. J Endocrinol (2008) 1.10
Brain uptake of thiamine-coated nanoparticles. J Control Release (2003) 1.03
Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats. J Pharm Sci (2009) 0.96
Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine. AAPS PharmSciTech (2010) 0.87
Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles. Int J Pharm (2012) 0.85
[Advance on study in anti-tumor mechamism of bererine (Ber)]. Zhongguo Zhong Yao Za Zhi (2007) 0.84